Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Co-Diagnostics Inc

CODX
Current price
1.29 USD +0.13 USD (+11.21%)
Last closed 1.18 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 34 556 416 USD
Yield for 12 month -58.39 %
Week
Month
Year
CODX
21.11.2021 - 28.11.2021

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. Address: 2401 South Foothill Drive, Salt Lake City, UT, United States, 84109

Analytics

WallStreet Target Price

3 USD

P/E ratio

Dividend Yield

Current Year

+34 218 209 USD

Last Year

+97 885 603 USD

Current Quarter

+2 457 098 USD

Last Quarter

+197 806 USD

Current Year

+28 737 117 USD

Last Year

+86 310 659 USD

Current Quarter

+2 201 326 USD

Last Quarter

-261 289 USD

Key Figures CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -40 397 624 USD
Operating Margin TTM -363.68 %
PE Ratio
Return On Assets TTM -20.28 %
PEG Ratio
Return On Equity TTM -36.31 %
Wall Street Target Price 3 USD
Revenue TTM 4 658 344 USD
Book Value 3.25 USD
Revenue Per Share TTM 0.16 USD
Dividend Share
Quarterly Revenue Growth YOY -51.8 %
Dividend Yield
Gross Profit TTM 28 737 117 USD
Earnings Share -1.39 USD
Diluted Eps TTM -1.39 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY 30.8 %
Profit Margin

Dividend Analytics CODX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 16
Enterprise Value Revenue 0.1837
Price Sales TTM 1.4524
Enterprise Value EBITDA -0.0407
Price Book MRQ 0.6346

Financials CODX

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CODX

For 52 weeks

0.98 USD 3.34 USD
50 Day MA 1.13 USD
Shares Short Prior Month 699 607
200 Day MA 1.47 USD
Short Ratio 12.79
Shares Short 489 346
Short Percent 1.62 %